A brief overview of the key points discussed during a company’s quarterly earnings call, including financial performance, guidance, and management’s commentary on future outlook.
Sichuan Hexie Shuangma Earnings
Estimates
Actual
Y-on-Y Change
Revenue
EPS
Transcripts
Events
About Sichuan Hexie Shuangma Co., Ltd.
Sichuan Hexie Shuangma Co., Ltd.
000935
Sichuan Hexie Shuangma Co., Ltd. manufactures and sells building material products in China. The company offers cement, commercial clinker, and aggregates used for infrastructure, industrial park construction, municipal livelihood projects, commercial housing development, urban renewal, and rural revitalization. It is also involved in biopharmaceutical research and development and production business; and private equity investment fund management business. In addition, the company engages in peptide API research and development, and production; peptide contract customization; customized research and development, and production business; and beauty peptide research and development, and production business. Further, it offers semaglutide, liraglutide, and tilpotide targeting major chronic diseases; and invest in manufacturing and new energy industries, including photovoltaics, chip design and manufacturing, consumer electronics, intelligent equipment, industrial automation, new energy, autonomous driving, and semiconductor equipment. The company was formerly known as SICHUAN SHUANGMA CEMENT CO., Ltd and changed its name to Sichuan Hexie Shuangma Co., Ltd. in February 2022. Sichuan Hexie Shuangma Co., Ltd. was founded in 1998 and is based in Chengdu, China.
Sichuan Hexie Shuangma Co., Ltd. manufactures and sells building material products in China. The company offers cement, commercial clinker, and aggregates used for infrastructure, industrial park construction, municipal livelihood projects, commercial housing developm...
Sichuan Hexie Shuangma Co., Ltd. manufactures and sells building material products in China. The company offers cement, commercial clinker, and aggregates used for infrastructure, industrial park construction, municipal livelihood projects, commercial housing development, urban renewal, and rural revitalization. It is also involved in biopharmaceutical research and development and production business; and private equity investment fund management business. In addition, the company engages in peptide API research and development, and production; peptide contract customization; customized research and development, and production business; and beauty peptide research and development, and production business. Further, it offers semaglutide, liraglutide, and tilpotide targeting major chronic diseases; and invest in manufacturing and new energy industries, including photovoltaics, chip design and manufacturing, consumer electronics, intelligent equipment, industrial automation, new energy, autonomous driving, and semiconductor equipment. The company was formerly known as SICHUAN SHUANGMA CEMENT CO., Ltd and changed its name to Sichuan Hexie Shuangma Co., Ltd. in February 2022. Sichuan Hexie Shuangma Co., Ltd. was founded in 1998 and is based in Chengdu, China.
Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach. Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.